Think beyond paper leaflets: electronic Product Information (ePI) by PharmaLedger is a convenient, secure, precise, and trusted solution that allows anyone with a smartphone to scan a medicine package and receive the correct product information directly from the manufacturer. Traditionally, drug manufacturers have produced paper leaflets with regulated information about medication, including instructions for use, important warnings, and possible side effects. However, paper leaflets are hard to read, cumbersome to navigate and inconvenient to store, and despite best efforts they are not delivered in a user-friendly or patient-centric way. ePI by PharmaLedger, developed through the collaboration of pharmaceutical companies, patient organizations, and technology and regulatory SMEs, was released to PharmaLedger Association (PLA) members in Q2 of 2023. The solution responds to an unmet need in healthcare for an easy-to-use medicine leaflet that doesn’t compromise on user experience, security, trust, accuracy or reliability. With ePI by PharmaLedger, end users get the right product information, every time. ePI by PharmaLedger is the heart of the PLA’s Product Trust platform and portfolio, which exists to enable the secure sharing of pharmaceutical and medical product information. Product Trust also includes the Detecting Falsified Medicines project, which delivers a Multi-Factor Packaging Authentication (MFPA) and the ACDC analytics capabilities as a stand-alone end user application, or as an additional functionality of ePI by PharmaLedger.